The store will not work correctly when cookies are disabled.
Prop-2-yn-1-yl 2,3-dideoxy-alpha-D-glycero-hex-2-enopyranosid-4-ulose
ID: ALA4084583
PubChem CID: 10797494
Max Phase: Preclinical
Molecular Formula: C9H10O4
Molecular Weight: 182.18
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: C#CCO[C@@H]1C=CC(=O)[C@@H](CO)O1
Standard InChI: InChI=1S/C9H10O4/c1-2-5-12-9-4-3-7(11)8(6-10)13-9/h1,3-4,8-10H,5-6H2/t8-,9+/m1/s1
Standard InChI Key: VTRSPGOWGYQRHX-BDAKNGLRSA-N
Molfile:
RDKit 2D
13 13 0 0 0 0 0 0 0 0999 V2000
18.6047 -3.9959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6047 -4.8210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3168 -5.2293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0288 -4.8210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0288 -3.9959 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.3168 -3.5793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3168 -2.7542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0313 -2.3417 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.7426 -5.2345 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.8890 -3.5855 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.4578 -4.8231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1717 -5.2366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8840 -5.6460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 1
7 8 1 0
4 9 1 6
1 10 2 0
9 11 1 0
11 12 1 0
12 13 3 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 182.18 | Molecular Weight (Monoisotopic): 182.0579 | AlogP: -0.52 | #Rotatable Bonds: 3 |
Polar Surface Area: 55.76 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 0.34 | CX LogD: 0.34 |
Aromatic Rings: ┄ | Heavy Atoms: 13 | QED Weighted: 0.60 | Np Likeness Score: 1.13 |
References
1. Santos JAM, Santos CS, Almeida CLA, Silva TDS, Freitas Filho JR, Militão GCG, da Silva TG, da Cruz CHB, Freitas JCR, Menezes PH.. (2017) Structure-based design, synthesis and antitumoral evaluation of enulosides., 128 [PMID:28189083] [10.1016/j.ejmech.2017.01.036] |